课题基金 / 基金详情

Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes

Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
长效胰岛素和中性鱼精蛋白哈格多恩 (NPH) 胰岛素在 2 型糖尿病患者中的有效性和安全性比较
批准号：
435226
负责人：
Filion Kristian B
金额：
$10.03万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-10-01 至 2022-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=435226&lang=en
关键词：
Cardiovascular Events Cohort Study Comparative Effectiveness Drug Safety Hypoglycemia Insulin Pharmacoepidemiology Population Health Type 2 Diabetes

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 2 diabetes is characterized by elevated blood sugar levels. Treatments include lifestyle modification (e.g., diet, exercise), use of oral drugs, and then insulin when other treatments fail to control blood sugar levels. However, insulin can cause po
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
A population-based assessment of pharmacological treatments for gestational diabetes
A personalized dynamic blood pressure control plan for cardiovascular disease prevention among patients with hypertension at low cardiovascular disease risk.
海外基金